Home Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population
Article
Licensed
Unlicensed Requires Authentication

Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population

  • Eun-Kee Park , Paul S. Thomas , Jenette Creaney , Anthony R. Johnson , Bruce W. Robinson and Deborah H. Yates
Published/Copyright: March 26, 2010

Abstract

Background: Soluble mesothelin-related protein (SMRP) is increased in the sera of patients with malignant mesothelioma (MM), and has been suggested as a diagnostic tool for MM in an asbestos exposed population. However, factors affecting SMRP concentrations in normal subjects and those with other asbestos related disorders have not been investigated in any large population based study.

Methods: Five hundred and thirty-eight subjects with a history of asbestos exposure were studied. Age, height, weight, body mass index (BMI), serum creatinine and glucose, estimated glomerular filtration rate (eGFR) and lung function were compared with SMRP concentrations.

Results: The mean age [± standard deviation (SD)] of participants was 66.9 (±10.1) years, and mean (±SD) serum SMRP concentration was 0.91 (±0.67) nmol/L. SMRP values were inversely associated with weight (Pearson r=–0.1254, p=0.0036), BMI (Pearson r=–0.1594, p=0.0002), blood glucose (Pearson r=–0.1515, p=0.0004), single-breath carbon monoxide diffusing capacity (DLco) % predicted (Pearson r=–0.1847, p<0.0001), eGFR (Pearson r=–0.2835, p<0.0001) and single-breath carbon monoxide diffusing capacity per unit alveolar volume (DLco/VA)% predicted (Pearson r=–0.1872, p<0.0001) but were positively associated with age (Pearson r=0.2315, p<0.0001) and creatinine (Pearson r=0.3833, p<0.0001).

Conclusions: This study has shown that demographic variables, physiological factors and lung function are associated with serum SMRP concentrations. Confounding factors should be considered when interpreting serum SMRP.

Clin Chem Lab Med 2010;48:869–74.


Corresponding author: Deborah H. Yates, MD, Department of Thoracic Medicine, St Vincent's Hospital, Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia Phone: +61-2-8382-2330, Fax: +61-2-8382-2359,

Received: 2009-12-18
Accepted: 2010-2-1
Published Online: 2010-03-26
Published in Print: 2010-06-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. The “Obamanomics”: a revolution in laboratory diagnostics
  3. Skeletal muscle biomarkers: not new but still interesting diagnostic tools
  4. Necessity for high-quality reference materials in the harmonization of laboratory assays
  5. Reviews
  6. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features
  7. Biochemical markers of muscular damage
  8. Minireview
  9. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory?
  10. Guidelines and Recommendations
  11. 2010 Consensus statement on the worldwide standardization of the hemoglobin A1c measurement
  12. Genetics and Molecular Diagnostics
  13. Development of a low-cost real-time reverse transcriptase-polymerase chain reaction technique for the detection and quantification of hepatitis C viral load
  14. Microsatellite polymorphisms in intron 2 of the toll-like receptor 2 gene and their association with susceptibility to pulmonary tuberculosis in Han Chinese
  15. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy
  16. General Clinical Chemistry and Laboratory Medicine
  17. Traceability of values for catalytic activity concentration of enzymes: a Certified Reference Material for aspartate transaminase
  18. Development and preparation of a new serum protein reference material: feasibility studies and processing
  19. A WHO Reference Reagent for the Serum Transferrin Receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation
  20. Hyperhomocysteinemia is not associated with reduced bone quality in humans with hip osteoarthritis
  21. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios
  22. New quantitative electrochemiluminescence method (ECLIA) for interleukin-6 (IL-6) measurement
  23. Evaluation of cell counting and leukocyte differentiation in cerebrospinal fluid controls using hematology analyzers by the German Society for Clinical Chemistry and Laboratory Medicine
  24. Reference Values and Biological Variations
  25. The relationship of coffee and green tea consumption with high-sensitivity C-reactive protein in Japanese men and women
  26. Cancer Diagnostics
  27. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
  28. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer
  29. Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population
  30. Cardiovascular Diseases
  31. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome
  32. Performance characteristics of a microfluidic Lab-on-Chip electrophoresis system for high-density lipoprotein (HDL) subfraction separation and measurement
  33. Letters to the Editor
  34. Hemolysis correction factor in the measurement of serum neuron-specific enolase
  35. Serum paraoxonase-1 activity and genetic polymorphisms: common errors in measurement and interpretation of results
  36. Neuropharmacology of schizophrenia: is there a role for leptin?
  37. Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.165/html
Scroll to top button